Michael Shetzline
CIK: 0001808509
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IRONWOOD PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 10, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct136.6K shares- - Feb 24, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct17K shares at avg. $3.66$62K - Feb 23, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct15.6K shares at avg. $3.81$59K - Feb 10, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct133.3K shares- - Feb 10, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct41.3K shares at avg. $1.76$73K - Jan 17, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct48.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 136,612 | - | $0 | Direct |
| Feb 24, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 17,012 | $3.66 | $62,264 | Direct |
| Feb 23, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 15,570 | $3.81 | $59,322 | Direct |
| Feb 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 133,333 | - | - | Direct |
| Feb 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 41,269 | $1.76 | $72,633 | Direct |
| Jan 17, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 48,224 | - | $0 | Direct |
1-6 of 6 transactions
About Shetzline Michael
Shetzline Michael (SEC CIK 0001808509) files insider reports with the SEC as SVP, CMO, Head-Res&Drug of IRONWOOD PHARMACEUTICALS INC (IRWD).
Signal8 holds 4 ownership filings by Shetzline Michael, all Form 4s, filed between Jan 22, 2025 and Mar 12, 2026. Those filings report 6 transactions, from Jan 17, 2025 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shetzline Michael's filings is in BOSTON, MA.
Recent filings by Shetzline Michael
- Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
- Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Feb 10, 2025: Grant or award of IRWD shares (Form 4, code A).
- Feb 10, 2025: Open-market sale of IRWD shares (Form 4, code S).
Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)
- DENNER ALEXANDER J, Director
- Silber Jeffrey, SVP, CMO, Head-Res&Drug
- Silver Ronald, PFO & PAO
- Shepard Jay, Director
- Kessler Marla L, Director
- Currie Mark G, Director